Barriers to the delivery of optimal antidiabetic therapy in the Middle East and Africa

International Journal of Clinical Practice

Volumn 68, Issue 4, 2014, Pages 503-511

  Almaatouq, M A ^a   Al Arouj, M ^b   Amod, A ^c   Assaad Khalil, S H ^d   Assaad, S N ^d   Azar, S T ^e   Esmat, K ^f   Hassoun, A A K ^g   Jarrah, N ^h   Zatari, S ⁱ  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b Dasman Center for Research and Treatment of Diabetes   (Kuwait)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d ALEXANDRIA UNIVERSITY   (Egypt)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^f Merck Serono Dubai   (United Arab Emirates)

^g Dubai Academic Health Corporation   (United Arab Emirates)

^h MUTAH UNIVERSITY   (Jordan)

ⁱ King Abdallah Medical City ^*  (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CATHA EDULIS EXTRACT; INSULIN;

AFRICA; ALTERNATIVE MEDICINE; CULTURAL FACTOR; DEMOGRAPHY; DIABETES EDUCATION; DIET; DOCTOR PATIENT RELATION; ECONOMIC ASPECT; EDUCATION; EXERCISE; FAMILY LIFE; FOLLOW UP; GENDER; GLYCEMIC CONTROL; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HUMAN; MIDDLE EAST; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELIGION; REVIEW; SOCIAL ASPECT; TOBACCO USE; CULTURAL ANTHROPOLOGY; DIABETES MELLITUS, TYPE 2; EDUCATIONAL STATUS; EPIDEMIOLOGY; FEMALE; MALE; POVERTY; SEX DIFFERENCE; SOCIOECONOMICS;

AFRICA; CULTURE; DIABETES MELLITUS, TYPE 2; EDUCATIONAL STATUS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE EAST; POVERTY; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 84897422469     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12342     Document Type: Review

References (70)

1. International Diabetes Federation. Global guideline for the management of type 2 diabetes. www.idf.org/guidelines (accessed February 2012).
2. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2009; 32: 193-203.
3. International Diabetes Federation. International Diabetes Federation E-atlas of Diabetes, 5th edn. http://www.eatlas.idf.org (accessed April 2013).
4. Al-Maatouq M, Al-Arouj M, Assaad SH, et al. Optimising the medical management of hyperglycaemia in type 2 diabetes in the Middle East: pivotal role of metformin. Int J Clin Pract 2010; 64: 149-59.
5. Almahmeed W, Arnaout MS, Chettaoui R, et al. Current status of β-blockade for the management of cardiovascular disease in Africa and the Middle-East. Ther Clin Risk Manag 2012; 8: 65-72.
6. Al-Elq AH,. Current practice in the management of patients with type 2 diabetes mellitus in Saudi Arabia. Saudi Med J 2009; 30: 1551-6.
7. Abou El-Enein NY, Abolfotouh MA,. An audit of diabetes care at 3 centres in Alexandria. East Mediterr Health J 2008; 14: 636-46.
8. Herman WH, Aubert RE, Engelgau MM, et al. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabet Med 1998; 15: 1045-51.
9. Akel M, Hamadeh G,. Quality of diabetes care in a university health center in Lebanon. Int J Qual Health Care 1999; 11: 517-21.
10. Saadi H, Carruthers SG, Nagelkerke N, et al. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clinical Pract 2007; 78: 369-77.
11. Rotchford AP, Rotchford KM,. Diabetes in rural South Africa-an assessment of care and complications. S Afr Med J 2002; 92: 536-41.
12. Reed RL, Revel AO, Carter A, Saadi HF, Dunn EV,. A clinical trial of chronic care diabetic clinics in general practice in the United Arab Emirates: a preliminary analysis. Arch Physiol Biochem 2001; 109: 272-80.
13. Bradshaw D, Schneider M, Dorrington R, Bourne DE, Laubscher R,. South African cause-of-death profile in transition-1996 and future trends. S Afr Med J 2002; 92: 618-23.
14. Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D,. The burden of non-communicable diseases in South Africa. Lancet 2009; 374: 934-47.
15. Vorster HH, Venter CS, Wissing MP, Margetts BM,. The nutrition and health transition in the North West Province of South Africa: a review of the THUSA (Transition and Health during Urbanisation of South Africans) study. Public Health Nutr 2005; 8: 480-90.
16. Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM,. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract 2008; 62: 76-87.
17. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE,. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004; 27: 2800-5.
18. Asche C, LaFleur J, Conner C,. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther 2011; 33: 74-109.
19. Hong JS, Kang HC,. Relationship between oral antihyperglycemic medication adherence and hospitalization, mortality, and healthcare costs in adult ambulatory care patients with type 2 diabetes in South Korea. Med Care 2011; 49: 378-84.
20. Yu AP, Yu YF, Nichol MB,. Estimating the effect of medication adherence on health outcomes among patients with type 2 diabetes-an application of marginal structural models. Value Health 2010; 13: 1038-45.
21. Wens J, Vermeire E, Royen PV, Sabbe B, Denekens J,. GPs' perspectives of type 2 diabetes patients' adherence to treatment: a qualitative analysis of barriers and solutions. BMC Fam Pract 2005; 6: 20.
22. Sherman BW, Sekili A, Prakash ST, Rausch CA,. Physician-specific variation in medication adherence among diabetes patients. Am J Manag Care 2011; 17: 729-36.
23. Ibrahim NK, Attia SG, Sallam SA, Fetohy EM, El-Sewi F,. Physicians' therapeutic practice and compliance of diabetic patients attending rural primary health care units in Alexandria. J Family Community Med 2010; 17: 121-8.
24. Khoza SR, Kortenbout W,. An investigation of compliance in type II diabetic patients attending clinic at Church of Scotland hospital. Curationis 1995; 18: 10-4.
25. Kagee A, Le Roux M, Dick J,. Treatment adherence among primary care patients in a historically disadvantaged community in South Africa: a qualitative study. J Health Psychol 2007; 12: 444-60.
26. Mahfouz EM, Awadalla HI,. Compliance to diabetes self-management in rural El-Mina, Egypt. Cent Eur J Public Health 2011; 19: 35-41.
27. Mansour AA,. Patients' opinion on the barriers to diabetes control in areas of conflicts: the Iraqi example. Confl Health 2008; 2: 7.
28. Zolfaghari M, Mousavifar SA, Pedram S, Haghani H,. The impact of nurse short message services and telephone follow-ups on diabetic adherence: which one is more effective? J Clin Nurs 2012; 21: 1922-31.
29. Sharaf F,. Impact of health education on compliance among patients of chronic diseases in Al Qassim, Saudi Arabia. Int J Health Sci (Qassim) 2010; 4: 139-48.
30. Al-Saeedi M, Elzubier AG, Bahnassi AA, Al-Dawood KM,. Patterns of belief and use of traditional remedies by diabetic patients in Mecca, Saudi Arabia. East Mediterr Health J 2003; 9: 99-107.
31. Khalaf AJ, Whitford DL,. The use of complementary and alternative medicine by patients with diabetes mellitus in Bahrain: a cross-sectional study. BMC Complement Altern Med 2010; 10: 35.
32. Haque M, Emerson SH, Dennison CR, Navsa M, Levitt NS,. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. S Afr Med J 2005; 95: 798-802.
33. Alavi NM, Alami L, Taefi S, Gharabagh GS,. Factor analysis of self-treatment in diabetes mellitus: a cross-sectional study. BMC Public Health 2011; 11: 761.
34. Alberti H, Boudriga N, Nabli M,. Primary care management of diabetes in a low/middle income country: a multi-method, qualitative study of barriers and facilitators to care. BMC Fam Pract 2007; 8: 63.
35. World Health Organisation. World Health Statistics 2009. http://www.who.int/whosis/whostat/2009/en/index.html (accessed April 2013).
36. Soliman AR, Fathy A, Roshd D,. The growing burden of end-stage renal disease in Egypt. Ren Fail 2012; 34: 425-8.
37. Bawadi HA, Ammari F, Abu-Jamous D, Khader YS, Bataineh S, Tayyem RF,. Food insecurity is related to glycemic control deterioration in patients with type 2 diabetes. Clin Nutr 2012; 31: 250-4.
38. Bruno G, Landi A,. Epidemiology and costs of diabetes. Transplant Proc 2011; 43: 327-9.
39. Abdelmoneim I, Al-Homrany MA,. Health education in the management of diabetes at the primary health care level: is there a gender difference? East Mediterr Health J 2002; 8: 18-23.
40. Al-Daghri NM, Al-Attas OS, Alokail MS, et al. Gender-specific associations between insulin resistance, hypertension, and markers of inflammation among adult Saudis with and without diabetes mellitus type 2. Adv Med Sci 2010; 55: 179-85.
41. Yekta Z, Pourali R, Ghasemi-Rad M,. Comparison of demographic and clinical characteristics influencing health-related quality of life in patients with diabetic foot ulcers and those without foot ulcers. Diabetes Metab Syndr Obes 2011; 4: 393-9.
42. Midhet FM, Al-Mohaimeed AA, Sharaf FK,. Lifestyle related risk factors of type 2 diabetes mellitus in Saudi Arabia. Saudi Med J 2010; 31: 768-74.
43. Ali HI, Baynouna LM, Bernsen RM,. Barriers and facilitators of weight management: perspectives of Arab women at risk for type 2 diabetes. Health Soc Care Community 2010; 18: 219-28.
44. Nour El-Din MM, Al-Mulhim NA, Abdel Gawwad ES,. Factors associated with hospitalization for type 2 diabetic patients at a teaching hospital in Saudi Arabia. J Egypt Public Health Assoc 2009; 84: 1-19.
45. el-Shazly M, Zaki A, Nicolucci A,. Care-related risk factors for chronic diabetic complications in developing countries: a case from Egypt. Public Health 2002; 116: 289-96.
46. Alberti H, Alberti B,. The influence of gender on the primary care management of diabetes in Tunisia. Pan Afr Med J 2009; 22 (3): 2.
47. Bulatova NR, Yousef AM, AbuRuz SM,. Antiplatelet therapy for primary and secondary prevention in Jordanian patients with diabetes mellitus. Thromb Res 2007; 121: 43-50.
48. Khattab MS, Aboifotouh MA, Khan MY, Humaidi MA, al-Kaldi YM,. Compliance and control of diabetes in a family practice setting, Saudi Arabia. East Mediterr Health J 1999; 5: 755-65.
49. Puoane T, Tsolekile L, Steyn N,. Perceptions about body image and sizes among Black African girls living in Cape Town. Ethn Dis 2010; 20: 29-34.
50. Serour M, Alqhenaei H, Al-Saqabi S, Mustafa AR, Ben-Nakhi A,. Cultural factors and patients' adherence to lifestyle measures. Br J Gen Pract 2007; 57: 291-5.
51. Al-Hazzaa HM, Abahussain NA, Al-Sobayel HI, Qahwaji DM, Musaiger AO,. Physical activity, sedentary behaviors and dietary habits among Saudi adolescents relative to age, gender and region. Int J Behav Nutr Phys Act 2011; 8: 140.
52. Abdoli S, Ashktorab T, Ahmadi F, Parvizy S, Dunning T,. Religion, faith and the empowerment process: stories of Iranian people with diabetes. Int J Nurs Pract 2011; 17: 289-98.
53. Ageely HM,. Prevalence of Khat chewing in college and secondary (high) school students of Jazan region, Saudi Arabia. Harm Reduct J 2009; 6: 11.
54. Al-Dubai SA, Rampal KG,. Prevalence and associated factors of burnout among doctors in Yemen. J Occup Health 2010; 52: 58-65.
55. Ali WM, Al Habib KF, Al-Motarreb A, et al. Acute coronary syndrome and Khat herbal amphetamine use: an observational report. Circulation 2011; 124: 2681-9.
56. Nasir LS, Nasir AK,. Introducing Arabic language patient education materials in Jordan. Patient Educ Couns 2006; 60: 142-5.
57. Ahmedani MY, Ul Haque MS, Basit A, Fawwad A, Alvi SF,. Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education. Diabet Med 2012; 29: 709-15.
58. Almaatouq MA,. Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan. Diabetes Metab Syndr Obes 2012; 5: 109-19.
59. Al-Saeedi M, Elzubier AG, Bahnassy AA, Al-Dawood KM,. Treatment-related misconceptions among diabetic patients in Western Saudi Arabia. Saudi Med J 2002; 23: 1243-6.
60. Lamchahab FZ, El Kihal N, Khoudri I, Chraibi A, Hassam B, Ait Ourhroui M,. Factors influencing the awareness of diabetic foot risks. Ann Phys Rehabil Med 2011; 54: 359-65.
61. Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M,. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci 2011; 16: 43-9.
62. Baghianimoghadam MH, Afkhami, Ardekani M, Baghianimoghadam B,. Effect of education on improvement of quality of life by SF-20 in type 2 diabetic patients. Acta Med Indones 2009; 41: 175-80.
63. Aflakseir A,. The role of illness and medication perceptions on adherence to medicines in a group of Iranian patients with type 2 diabetes. J Diabetes 2012; 4: 243-7.
64. Daniels A, Biesma R, Otten J, et al. Ambivalence of primary health care professionals towards the South African guidelines for hypertension and diabetes. S Afr Med J 2000; 90: 1206-11.
65. Abueleinen KG, El-Mekawey H, Saif YS, Khafagy A, Rizk HI, Eltahlawy EM,. Sociodemographic factors responsible for blindness in diabetic Egyptian patients. Clin Ophthalmol 2011; 5: 1593-8.
66. Morowatisharifabad MA, Mahmoodabad SS, Baghianimoghadam MH, Tonekaboni NR,. Relationships between locus of control and adherence to diabetes regimen in a sample of Iranians. Int J Diabetes Dev Ctries 2010; 30: 27-32.
67. Aljasem LI, Peyrot M, Wissow L, Rubin RR,. The impact of barriers and self-efficacy on self-care behaviors in type 2 diabetes. Diabetes Educ 2001; 27: 393-404.
68. Al-Khaldi YM, Khan MY,. Audit of a diabetic health education program at a large Primary Health Care Center in Asir region. Saudi Med J 2000; 21: 838-42.
69. Afandi B, Ahmad S, Saadi H, et al. Audit of a diabetes clinic at Tawam Hospital, United Arab Emirates, 2004-2005. Ann N Y Acad Sci 2006; 1084: 319-24.
70. Moharram MM, Farahat FM,. Quality improvement of diabetes care using flow sheets in family health practice. Saudi Med J 2008; 29: 98-101.